Showing 833–848 of 1155 results
The Oncomine Acute Myeloid Leukaemia (AML) Panel is a targeted next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of AML. It enables simultaneous detection of key mutations, gene fusions, and copy number variations across clinically relevant genes associated with AML.
The Oncomine Comprehensive Myeloid/Leukemia Panel (DNA + RNA fusions) is a next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of myeloid malignancies and leukemias. It simultaneously analyzes DNA and RNA to detect key mutations, copy number variations, and gene fusions across a broad range of clinically relevant genes.
The Oncomine Myelodysplastic Syndrome (MDS) Panel detects genetic mutations linked to MDS and blood cancers. Accurate, next-generation sequencing. Book your test today.
The Oncomine Myeloproliferative Neoplasm (MPN) Panel is a targeted next-generation sequencing (NGS) assay designed for the comprehensive detection of key driver mutations in myeloproliferative neoplasms. It enables the simultaneous analysis of JAK2, CALR, and MPL genes, which are critical for MPN diagnosis and classification. The panel offers high sensitivity, detecting low-frequency variants with as little as 10 ng of input RNA or DNA, making it ideal for limited or degraded samples.
The Oncotype DX Breast Cancer (ML) Test is a genomic assay that analyzes the activity of 21 genes in a breast cancer tumor to predict the risk of recurrence and the potential benefit of chemotherapy. Designed for early-stage, hormone receptor-positive, HER2-negative breast cancer patients, it provides a Recurrence Score® result that helps guide personalized treatment decisions. Key benefits include reducing unnecessary chemotherapy, improving patient outcomes, and offering evidence-based insights backed by extensive clinical validation.
Sample Type : Buccal Swab
Methodology : PCR
TAT : 14 Days
An Open MRI Scan (Without Contrast) is a non-invasive imaging procedure that uses magnetic fields and radio waves to create detailed internal body images without the need for contrast dye. Its key features include an open design, making it ideal for claustrophobic or anxious patients, and high-resolution imaging for accurate diagnosis.
The Open MRI Scan With Contrast is an advanced diagnostic imaging procedure designed for enhanced patient comfort and precise results. Unlike traditional closed MRI machines, the open design reduces anxiety and claustrophobia, making it ideal for children, elderly patients, and those with mobility issues.
Get the Organic Acid Quantification by GC/MS in Dubai to detect metabolic imbalances, mitochondrial dysfunction & nutrient deficiencies. Results in 21 days. Book now!
Sample Type : Early Morning Urine
Methodology : Gas Phase Chromatography / Mass Spectrometry (GC-MS)
TAT : 21 Days
Sample Type : Early Morning Urine
Methodology : HPLC – High Performance Liquid Chromatography
TAT : 21 Days
